We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Crexendo
CXDO
$215M
| $66.9K | ﹤0.01% |
10,844
-160
| -1% | -$1.05K |
|
3177
Torrid Holdings
CURV
$247M
| $66K | ﹤0.01% |
37,060
+628
| +2% | +$776 |
|
3178
Strawberry Fields REIT
STRW
$192M
| $65.9K | ﹤0.01% |
5,540
+110
| +2% | +$1.41K |
|
|
CANF
3179
Can-Fite BioPharma American Depositary Shares
CANF
$6.83M
| $64.8K | ﹤0.01% |
20,908
+6,814
| +48% | +$28.2K |
|
3180
Finance of America Companies
FOA
$204M
| $64K | ﹤0.01% |
3,857
-288
| -7% | -$5.95K |
|
3181
Definitive Healthcare
DH
$72.1M
| $63.9K | ﹤0.01% |
51,986
-2,710
| -5% | -$4.71K |
|
|
MAPS
3182
DELISTED
WM TECHNOLOGY INC A
MAPS
| $63.1K | ﹤0.01% |
95,898
-12,505
| -12% | -$9.18K |
|
3183
Vista Energy
VIST
$7.75B
| $63K | ﹤0.01% |
835
| – | – |
|
3184
First Majestic Silver
AG
$8.05B
| $62.4K | ﹤0.01% |
2,906
-2,850
| -50% | -$65.7K |
|
3185
Comp X International
CIX
$329M
| $61.3K | ﹤0.01% |
2,624
-41
| -2% | -$968 |
|
3186
HUTCHMED
HCM
$1.89B
| $61.3K | ﹤0.01% |
4,096
+64
| +2% | +$936 |
|
|
DRD
3187
DRDGold
DRD
$1.82B
| $60.9K | ﹤0.01% |
2,073
| – | – |
|
3188
Neuronetics
STIM
$120M
| $60.7K | ﹤0.01% |
41,843
-6,564
| -14% | -$10.4K |
|
3189
TriSalus Life Sciences
TLSI
$259M
| $60.2K | ﹤0.01% |
15,042
-386
| -3% | -$1.89K |
|
3190
Pulmonx
LUNG
$49.4M
| $59.8K | ﹤0.01% |
46,380
-9,861
| -18% | -$16.3K |
|
3191
TTEC Holdings
TTEC
$103M
| $59.7K | ﹤0.01% |
23,872
-1,224
| -5% | -$3.5K |
|
3192
BARK
BARK
$74.8M
| $59.3K | ﹤0.01% |
5,853
-64
| -1% | -$983 |
|
|
BCYC
3193
Bicycle Therapeutics
BCYC
$270M
| $58.3K | ﹤0.01% |
12,571
+1,400
| +13% | +$8K |
|
3194
SunPower Inc
SPWR
$81.7M
| $58.3K | ﹤0.01% |
45,912
-3,291
| -7% | -$4.95K |
|
|
AISP
3195
Airship AI Holdings
AISP
$69.2M
| $58K | ﹤0.01% |
25,665
-150
| -0.6% | -$425 |
|
|
PAMT
3196
PAMT Corp
PAMT
$340M
| $57.3K | ﹤0.01% |
6,787
-1,783
| -21% | -$19K |
|
3197
NIO
NIO
$11.3B
| $57.3K | ﹤0.01% |
9,503
-992
| -9% | -$5.01K |
|
3198
LifeVantage
LFVN
$82.4M
| $56K | ﹤0.01% |
12,957
+463
| +4% | +$2.42K |
|
3199
Lucid Diagnostics
LUCD
$173M
| $55.9K | ﹤0.01% |
48,630
-3,877
| -7% | -$4.93K |
|
|
EEX
3200
DELISTED
Emerald Holding
EEX
| $55.3K | ﹤0.01% |
12,259
+126
| +1% | +$581 |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.